Merck & Company, Inc. vs Zoetis Inc. — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
7.5
Bullish
Quality
Health
Growth
Valuation
Sentiment
MRK
Forward P/E of 11.5× is low relative to sector peers.
ZTS
High-quality business with 66% return on equity and 28% profit margins.
Analyst Consensus
BUY
Target $129.74 (+15.7%)
27 analysts
BUY
Target $148.88 (+30.4%)
17 analysts
Fundamentals
MRK
ZTS
31.5×
Trailing P/E
19.0×
11.5×
Forward P/E
15.1×
13.6%
Profit Margin
28.2%
76.6%
Gross Margin
71.9%
—
ROE
66.0%
4.9%
Revenue Growth
3.0%
—
Earnings Growth
6.1%
0.28
Beta
0.97
—
Price / Book
—
$277.0B
Market Cap
$48.2B
$73 – $125
52-Week Range
$113 – $172
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →